FDA Drug Application (202050) for OLANZAPINE by AUROBINDO PHARMA LTD

Back to FDA Applications sponsored by AUROBINDO PHARMA LTD

Application Number202050
Product Number001
FormTABLET;ORAL
Dosage2.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOLANZAPINE
Active IngredientOLANZAPINE

Active IngredientCount
List of drugs with Active Ingredient OLANZAPINE5


Back to FDA Applications sponsored by AUROBINDO PHARMA LTD